Evidence map›Paper›PMID 39254707›Full record

ReviewAbdominal radiology (New York)2025

Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse.

Valdair Francisco Muglia, Ludovica Laschena, Martina Pecoraro, Gabriel de Lion Gouvea, Leandro Machado Colli, Valeria Panebianco

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valdair Francisco MugliaDepartment of Medical Images, Oncology and Hematology, Ribeirao Preto Medical School, University of Sao Paulo, Hospital Clinicas Ribeirao Preto - Av. Bandeirantes 3900. Campus Monte Alegre -USP, Sao Paulo, 14049-900, Brazil. fmuglia@fmrp.usp.br.ORCID 0000-0002-4700-0599
Ludovica LaschenaDepartment of Radiological Sciences, Oncology and Pathology, Sapienza University, Rome, Italy.ORCID 0000-0001-8375-0912
Martina PecoraroDepartment of Radiological Sciences, Oncology and Pathology, Sapienza University, Rome, Italy.
Gabriel de Lion GouveaDepartment of Medical Images, Oncology and Hematology, Ribeirao Preto Medical School, University of Sao Paulo, Hospital Clinicas Ribeirao Preto - Av. Bandeirantes 3900. Campus Monte Alegre -USP, Sao Paulo, 14049-900, Brazil.ORCID 0000-0001-9638-2848
Leandro Machado ColliDepartment of Medical Images, Oncology and Hematology, Ribeirao Preto Medical School, University of Sao Paulo, Hospital Clinicas Ribeirao Preto - Av. Bandeirantes 3900. Campus Monte Alegre -USP, Sao Paulo, 14049-900, Brazil.ORCID 0000-0001-6928-1195
Valeria PanebiancoDepartment of Radiological Sciences, Oncology and Pathology, Sapienza University, Rome, Italy.ORCID 0000-0002-3091-8192

Funding

Next Generation Foundation PNRR-PE06_SPOKE_ 4
6 · The paper itself

Abstract

Prostate cancer (PCa) relapse, defined either by persistent PSA levels (after RP) or biochemical recurrence (BCR), is a common occurrence. The imaging evaluation of patients experiencing PCa relapse has undergone significant advancements in the past decade, notably with the introduction of new Positron Emission Tomography (PET) tracers such as Prostate-specific membrane antigen (PSMA), and the progress in functional Magnetic Resonance Imaging (MRI). This article will explore the role of traditional imaging, the evolution of MRI towards the development of the Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR) scoring system, and how next-generation imaging is enhancing diagnostic accuracy in the setting of PCa relapse, which is essential for adopting personalized strategies that may ultimately impact outcomes.

Indexed as

Magnetic Resonance ImagingNeoplasm Recurrence, LocalProstatic NeoplasmsHumansMalePositron-Emission TomographyBiochemical recurrenceMagnetic resonance imagingPositron emission tomographyProstate cancer

Identifiers

PMID39254707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.